These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 39156336)
1. A Comprehensive Review on the Efficacy and Safety of Vonoprazan in the Management of Gastric Acid-Related Diseases. Padwale V; Kirnake V; Daswani R; Kodmalwar A; Gupta A Cureus; 2024 Jul; 16(7):e64777. PubMed ID: 39156336 [TBL] [Abstract][Full Text] [Related]
2. Vonoprazan: A Novel and Potent Alternative in the Treatment of Acid-Related Diseases. Yang X; Li Y; Sun Y; Zhang M; Guo C; Mirza IA; Li YQ Dig Dis Sci; 2018 Feb; 63(2):302-311. PubMed ID: 29282636 [TBL] [Abstract][Full Text] [Related]
3. Vonoprazan Fumarate for the Treatment of Gastric Ulcers: A Short Review on Emerging Data. Marabotto E; Ziola S; Savarino V; Giannini EG; Furnari M; Bodini G; Zingone F; Ghisa M; Barberio B; Zentilin P; Savarino E Clin Exp Gastroenterol; 2020; 13():99-104. PubMed ID: 32346304 [TBL] [Abstract][Full Text] [Related]
4. Incidence and type of adverse events in patients taking vonoprazan: A systematic review and meta-analysis. Xu W; Bai Z; Shang Y; Wang J; Wong Y; Qi X Therap Adv Gastroenterol; 2023; 16():17562848231167858. PubMed ID: 37113190 [TBL] [Abstract][Full Text] [Related]
5. Vonoprazan fumarate for the management of acid-related diseases. Martinucci I; Blandizzi C; Bodini G; Marabotto E; Savarino V; Marchi S; de Bortoli N; Savarino E Expert Opin Pharmacother; 2017 Aug; 18(11):1145-1152. PubMed ID: 28657473 [TBL] [Abstract][Full Text] [Related]
6. A comparison of efficacy and safety of potassium-competitive acid blocker and proton pump inhibitor in gastric acid-related diseases: A systematic review and meta-analysis. Simadibrata DM; Syam AF; Lee YY J Gastroenterol Hepatol; 2022 Dec; 37(12):2217-2228. PubMed ID: 36181401 [TBL] [Abstract][Full Text] [Related]
7. Vonoprazan vs proton pump inhibitors in treating post-endoscopic submucosal dissection ulcers and preventing bleeding: A meta-analysis of randomized controlled trials and observational studies. Martin ; Zhou Y; Meng CX; Takagi T; Tian YS Medicine (Baltimore); 2020 Feb; 99(9):e19357. PubMed ID: 32118778 [TBL] [Abstract][Full Text] [Related]
9. Vonoprazan fumarate, a novel potassium-competitive acid blocker, in the management of gastroesophageal reflux disease: safety and clinical evidence to date. Sugano K Therap Adv Gastroenterol; 2018; 11():1756283X17745776. PubMed ID: 29383028 [TBL] [Abstract][Full Text] [Related]
10. Comparative Efficacy and Safety of Potassium-Competitive Acid Blockers vs. Proton Pump Inhibitors for Peptic Ulcer with or without Ouyang M; Zou S; Cheng Q; Shi X; Zhao Y; Sun M Pharmaceuticals (Basel); 2024 May; 17(6):. PubMed ID: 38931366 [TBL] [Abstract][Full Text] [Related]
11. Vonoprazan-associated Ouyang M; Zou S; Cheng Q; Shi X; Zhao Y; Sun M Ther Adv Drug Saf; 2024; 15():20420986241260211. PubMed ID: 39091466 [TBL] [Abstract][Full Text] [Related]
12. Vonoprazan: A New Potassium-Competitive Acid Blocker. St Onge E; Phillips B J Pharm Technol; 2023 Jun; 39(3):139-146. PubMed ID: 37323765 [No Abstract] [Full Text] [Related]